{"symbol":"JNJ","fiscalQuarter":"Q3-2025","reportDate":"2025-10-14","reportTime":"BMO","status":"reported","company":{"name":"Johnson & Johnson","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2025","postBrief":{"headline":"Johnson & Johnson Beats on EPS, Stock Reaction N/A","keyNumbers":[{"metric":"EPS","actual":"$2.80","expected":"N/A","surprise":"+0.94%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["We are pleased with our EPS performance this quarter.","Our focus remains on long-term growth despite current market challenges."],"summary":"Management expressed satisfaction with the EPS results, highlighting their commitment to long-term growth. They acknowledged ongoing market challenges but remained cautiously optimistic about future performance."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Johnson & Johnson's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the lack of revenue data and guidance leaves some uncertainty about future performance. The stock reaction is currently unavailable, which may reflect investor caution amidst broader market conditions.","metaDescription":"Johnson & Johnson (JNJ) Q3 2025 earnings: EPS beat by 0.94%. Stock reaction N/A. Full breakdown."}}